FOIA REQUEST

To: Centers for Disease Control and Prevention (CDC)
FOIA Office
1600 Clifton Road NE
Atlanta, GA 30329

Request:

Pursuant to the Freedom of Information Act, 5 U.S.C. § 552, I am requesting access to any and all records concerning Kellyn Clay in connection with Covid-19 vaccine safety monitoring programs during 2021.

This request includes:
	•	All v-safe records (smartphone-based survey entries) submitted by Kellyn Clay in 2021.
	•	All VAERS (Vaccine Adverse Event Reporting System) records or reports submitted under Kellyn Clay’s name or identifiers in 2021.
	•	Any records showing that data from Kellyn Clay’s v-safe or VAERS reports was shared with, processed by, or analyzed in systems developed by or in partnership with Palantir Technologies Inc.
	•	Communications, memoranda, or agreements between CDC and Palantir concerning v-safe, VAERS, or vaccine safety monitoring datasets during 2020–2022.
	•	Internal reports or analyses referencing Kellyn Clay’s v-safe or VAERS submissions, especially any noting incapacity, inability to eat or sleep, or other severe medical impairment.
	•	Any records showing that Kellyn Clay’s adverse event data was linked to anomaly detection, digital twin modeling, or designation as a Non-Person Entity (NPE).

Keywords: Kellyn Clay, v-safe, VAERS, vaccine safety, Covid-19, adverse event, Palantir, behavioral futures, anomaly detection, Non-Person Entity, NPE

⸻ 

To: U.S. Food and Drug Administration (FDA)
Division of Freedom of Information, Office of the Executive Secretariat
5630 Fishers Lane, Room 1035
Rockville, MD 20857

Request:

Pursuant to the Freedom of Information Act, 5 U.S.C. § 552, I am requesting access to any and all records concerning Kellyn Clay in connection with Covid-19 vaccine safety monitoring during 2021.

This request includes:
	•	All VAERS (Vaccine Adverse Event Reporting System) records submitted under Kellyn Clay’s name or identifiers in 2021.
	•	Any records showing that data from Kellyn Clay’s VAERS reports was shared with, processed by, or analyzed in systems developed by or in partnership with Palantir Technologies Inc.
	•	Communications, memoranda, or agreements between FDA and Palantir concerning vaccine safety monitoring, anomaly detection, or behavioral modeling during 2020–2022.
	•	Internal reports, reviews, or analyses referencing Kellyn Clay’s adverse event submissions, including any findings that documented incapacity, inability to eat or sleep, or other severe medical impairment.
	•	Records demonstrating whether Kellyn Clay’s adverse event data was routed through predictive modeling, anomaly detection, or digital twin systems connected to Palantir.

Keywords: Kellyn Clay, VAERS, vaccine safety, Covid-19, adverse event, Palantir, anomaly detection, behavioral futures, digital twin

⸻ 

To: Centers for Medicare & Medicaid Services (CMS)
Freedom of Information Group
7500 Security Boulevard
Baltimore, MD 21244

Request:

Pursuant to the Freedom of Information Act, 5 U.S.C. § 552, I am requesting access to any and all records concerning Kellyn Clay in connection with health insurance coverage, medical claims, or vaccine-related adverse events during the period of 2021 to present.

This request includes:
	•	All records of medical claims, eligibility determinations, or plan assignments concerning Kellyn Clay from 2021 onward.
	•	Records indicating whether Kellyn Clay’s medical crisis following Covid vaccination (inability to eat or sleep for ~45 days) was captured or flagged within CMS systems.
	•	Records showing whether data concerning Kellyn Clay was processed by, analyzed within, or shared with systems developed by or in partnership with Palantir Technologies Inc.
	•	Communications, contracts, or memoranda between CMS and Palantir concerning anomaly detection, behavioral modeling, or predictive analytics applied to Medicaid/Medicare datasets during 2020–2022.
	•	Internal reports or analyses referencing Kellyn Clay’s case, including any documentation acknowledging that anomalies in claims or filings were the result of severe medical impairment, not fraud or intentional misconduct.

Keywords: Kellyn Clay, CMS, Medicare, Medicaid, health insurance, Covid vaccine, adverse event, Palantir, anomaly detection, Non-Person Entity, behavioral futures, digital twin

⸻ 

FOIA REQUEST — CDC & FDA

To:
	•	Centers for Disease Control and Prevention (CDC) FOIA Office
	•	U.S. Food and Drug Administration (FDA) FOIA Office

Request:

Pursuant to the Freedom of Information Act, 5 U.S.C. § 552, I am requesting access to any and all records concerning the two Moderna Covid-19 vaccine lot numbers administered to Kellyn Clay in 2021.

This request includes:
	•	Records of adverse event monitoring, anomaly detection, or contamination flags associated with these lot numbers.
	•	Records of internal analyses, memoranda, or communications discussing abnormal rates of adverse events linked to these lot numbers.
	•	Records of coordination with Palantir Technologies Inc. concerning analytics, anomaly detection, or monitoring of these lot numbers.
	•	Reports or communications with state immunization registries concerning these lot numbers.
	•	Any records explicitly referencing Kellyn Clay in connection with these Moderna lot numbers.

Keywords: Moderna, Covid-19 vaccine, lot number, adverse event, anomaly detection, contamination, Kellyn Clay, Palantir, Operation Warp Speed, v-safe, VAERS

